13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-08-22 Event 2025-08-21 SEC 0001104659-25-081631 →

Meridian Venture Partners II GP, L.P. ANI PHARMACEUTICALS INC ANIP

Stake: 4.80% Shares: 1,034,570 CUSIP: 00182C103 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 12.02
3,584,301 shares short · -0.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $9.57M
Point72 Asset Mgmt

Other 13D/G Filings on ANI PHARMACEUTICALS INC

FiledFormFilerStakeShares
2025-03-13 SCHEDULE Meridian Venture Partners II GP, L.P. 5.40% 1,184,570 view →
2023-12-18 SC Meridian Venture Partners II GP, L.P. view →
2022-12-12 SC Meridian Venture Partners II GP, L.P. view →

Other Filings by Meridian Venture Partners II GP, L.P.

FiledFormIssuerStakeShares
2025-03-13 SCHEDULE ANI PHARMACEUTICALS INC ANIP 5.40% 1,184,570 view →
2023-12-18 SC ANI PHARMACEUTICALS INC ANIP view →
2022-12-12 SC ANI PHARMACEUTICALS INC ANIP view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →